Navigation Links
Nephros Provides Corporate Update
Date:11/20/2008

uce operating expenses and preserve its cash resources. Nephros has reduced its R&D staff to reflect the completion of its U.S. clinical trial and submission of the 510k application for the associated products.

"We have taken difficult, but necessary actions, to reduce fixed costs and redirect valuable cash resources to our revenue generating efforts. We appreciate the dedication and past efforts of those employees affected by this transition and thank them for their contributions," said Mr. Elgin.

Separately, Nephros has signed a lease for a new, less costly location in River Edge, NJ. Nephros has applied, and has been approved, for a grant from New Jersey's Business Employment Incentive Program (BEIP). The BEIP is an incentive grant from the State of New Jersey's Business Development Agency to help offset overhead expenses to attract companies to move to New Jersey. As a result of this program, Nephros will receive annual cash grants based on the number of new jobs it moves to New Jersey and all new jobs created by Nephros in the State of New Jersey for a ten year period. Nephros's relocation is anticipated to be completed by year-end.

The combined benefits of the reduction in headcount and the relocation of Nephros's offices will significantly reduce Nephros's fixed expenses going forward.

Outlook for Fourth Quarter and 2009

For the remainder of 2008, Nephros plans to focus its efforts on commercialization activities. Primary goals for Nephros in 2009 include expansion of DSU product sales for institutional infection control and preparation for the anticipated launch of Nephros's OLpur MD 220 Hemodiafilter, OLpur H2H Hemodiafiltration Module, and DSU products for dialysis centers in the U.S.

"For the immediate future, we are taking steps to increase our DSU marketing efforts and sales to hospitals, assisted living facilities, and rel
'/>"/>

SOURCE Nephros, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Nephros Receives Non-Compliance Notification from AMEX
2. Nephros Exhibiting at Maryland Ashe Conference July 20th-23rd
3. Nephros Appoints Gerald J. Kochanski as Chief Financial Officer
4. Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results
5. CJPS Enterprises Provides New Strategies To Create Additional Revenues for Companies with Intellectual Property
6. Nikon Instruments Provides Donation to Help Clemson University Start New Core Microscopy Facility
7. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
8. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
9. New Study Provides Key Findings for Biopharma Product Launch Evaluation
10. ConjuChem Provides Development Update
11. BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... ROCKVILLE, Md. , March 30, 2015 ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... China Food and Drug Administration (CFDA) has approved the ... trial in ovarian clear cell carcinoma (OCCC) patients for ...
(Date:3/30/2015)... 2015 Immunocore Limited, a ... treat cancer, viral infections and autoimmune disease, today ... Bell , the Regius Professor of Medicine at ... the Strategic Coordination of Health Research, to its ...      (Photo: http://photos.prnewswire.com/prnh/20150330/736483 ) , ...
(Date:3/29/2015)... March 29, 2015  Caris Life Sciences® ... in small cell cervical cancer (SCCC) that ... Intelligence®, the company,s panomic, comprehensive tumor profiling ... which may explain sensitivities and resistance to ... of certain biomarkers may guide treatment strategies ...
(Date:3/27/2015)... März 2015  Peter Walter wurde als ... für seine bahnbrechende Arbeit ausgewählt, die sich ... werden, sowie für die Entschlüsselung der Komponenten ... Stress nutzen, der mit der Ansammlung von ... für Biochemie an der University of California, ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4
... applicator, ATLANTA, Sept. 22 CryoLife, Inc. ... tissue processing company, announced,today that it has begun ... Hemostase MPH to control bleeding in general, cardiac ... in the U. S., the United,Kingdom and Germany ...
... WILMINGTON, Del., Sept. 22 For,his lifetime commitment in ... and other environmental exposures on the developing fetus and ... Robert,L. Brent, MD, PhD, will be honored as the ... Excellence in Children,s Health Care by Nemours,one of the ...
... and Preclinical Research at Upcoming Conferences, CALGARY, ... NASDAQ: ONCY) today announced the participation of five ... four conferences,through November 15, 2008 covering clinical trial ... important time for Oncolytics as we begin to ...
Cached Biology Technology:CryoLife Expands Distribution of Hemostase MPH(R) to Canada through Sorin Group Canada, Inc. 2CryoLife Expands Distribution of Hemostase MPH(R) to Canada through Sorin Group Canada, Inc. 3Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Children's Health Care 2Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial 2Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial 3
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
(Date:3/19/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... this week on Washington DC,s Fox ... segment "The Next Great Thing", host Laura Evans ... and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... March 17, 2015 Emotient, the leader ... today announced general availability of Emotient Analytics ... the analysis of facial expressions. The system analyzes ... content, products and services. It delivers audience response ... sentiment - as derived from facial evidence of ...
Breaking Biology News(10 mins):Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... research has uncovered an underutilized berry that could be the ... the Journal of Food Science , published by the ... amounts of lycopene and a related acidic compound, methyl-lycopenoate, which ... The bright red fruit has a tart flavor, and has ...
... world of the potential dangers of nuclear disposal and unforeseen ... detect the radioactive materials uranium and plutonium in waste water. ... appears in ACS, The Journal of Physical Chemistry C ... that it is highly likely that radioactive uranium and plutonium ...
... This news release is available in ... us have mixed feelings when remembering painful lessons in German or ... rules and patterns: using them correctly makes the difference between something ... at the University of Vienna have shown that sensitivity to very ...
Cached Biology News:Monkeys 'understand' rules underlying language musicality 2
... α-Amylase is a hydrolytic enzyme ... a mixture of glucose, maltose, maltotriose ... various fluids of the human,body are ... microbial,a-amylases are important enzymes for industry.4, ...
Rat monoclonal [20d5] to NKG2A + C+ E ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Mouse): CHO transfected cells expressing the B6 allele of NKG2A. Entrez Gen...
... Fluoroskan Ascent FL is ... and luminometric measurement technologies ... list of advanced features ... Luminoskan Ascent. Fluoroskan Ascent ...
... Thermo Forma's stainless steel ... patented adjustable mechanism that ... different shaking angles, and ... placement.This universal rack holder ...
Biology Products: